BeOne Medicines
John M. Fevig is a highly experienced medical writer and principal scientist with a robust background in drug discovery and development, particularly in the pharmaceutical industry. Since January 2020, John has held the position of Principal Medical Writer at BeiGene, also serving as Senior Medical Writer. Previously, John gained extensive experience at Covance, where responsibilities included leading the preparation of clinical study protocols and reports for Phase 1 clinical pharmacology studies. John's career includes significant roles at Bristol-Myers Squibb and DuPont Pharmaceuticals, contributing to major advancements in drug discoveries related to metabolic diseases, cardiovascular conditions, and obesity. John earned a Ph.D. in Organic Chemistry from the University of South Carolina and completed a postdoctoral fellowship at the University of California, Irvine.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.